Advanced search
Publication Cover
OncoImmunology Volume 4, 2015 - Issue 9
Submit an article Journal homepage
1,164
Views
6
CrossRef citations to date
0
Altmetric
Author's View

How to outsmart NK cell tolerance

Grzegorz TerszowskiDepartment of Biomedicine; University Hospital Basel; Basel, SwitzerlandCorrespondence[email protected]
,
Christian KleinRoche Pharma Research and Early Development; Roche Innovation Center Zurich; Schlieren, Switzerland
,
Laurent SchmiedDepartment of Biomedicine; University Hospital Basel; Basel, Switzerland
&
Martin SternDepartment of Biomedicine; University Hospital Basel; Basel, Switzerland;Roche Pharma Research and Early Development; Roche Innovation Center Zurich; Schlieren, Switzerland
Article: e1016708 | Received 29 Jan 2015, Accepted 03 Feb 2015, Published online: 15 Jun 2015

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Christian Klein, Marina Bacac, Pablo Umana & Günter Fingerle-Rowson. (2017) Combination therapy with the type II anti-CD20 antibody obinutuzumab. Expert Opinion on Investigational Drugs 26:10, pages 1145-1162.
Read now

Articles from other publishers (5)

Namita Varudkar, Elisabeth M. Shiffer, Jeremiah L. Oyer, Alicja Copik & Griffith D. Parks. (2023) Delivery of a novel membrane-anchored Fc chimera enhances NK cell-mediated killing of tumor cells and persistently virus-infected cells. PLOS ONE 18:5, pages e0285532.
Crossref
Laurent Schmied, Petter Höglund & Stephan Meinke. (2021) Platelet-Mediated Protection of Cancer Cells From Immune Surveillance – Possible Implications for Cancer Immunotherapy. Frontiers in Immunology 12.
Crossref
Ahmet Yilmaz, Hanwei Cui, Michael A. Caligiuri & Jianhua Yu. (2020) Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy. Journal of Hematology & Oncology 13:1.
Crossref
Tatsuki R. Kataoka, Chiyuki Ueshima, Masahiro Hirata, Sachiko Minamiguchi & Hironori Haga. (2020) Killer Immunoglobulin-Like Receptor 2DL4 (CD158d) Regulates Human Mast Cells both Positively and Negatively: Possible Roles in Pregnancy and Cancer Metastasis. International Journal of Molecular Sciences 21:3, pages 954.
Crossref
Christian Chabannon, Bechara Mfarrej, Sophie Guia, Sophie Ugolini, Raynier Devillier, Didier Blaise, Eric Vivier & Boris Calmels. (2016) Manufacturing Natural Killer Cells as Medicinal Products. Frontiers in Immunology 7.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.